CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, cilt.66, sa.5, ss.451-462, 2005 (SCI-Expanded)
Background: The most effective current therapy for hepatitis C virus (HCV) infection is the combination of pegylated interferon (peg-IFN) plus ribavirin (RBV).